0 items USD 0.00Search
- Did you mean
- clinic trials
Your search for "Clinical Trials" gave back 37 results.
A Pipeline Landscape Analysis and Comparative Assessment of Key Players: This report provides an update of recombinant coagulation factors used for...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
December 2014
Price: USD 2,680.00
This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016. Featured presentations of...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
November 2016
Price: USD 225.00
This pdf report contains information about Bispecific Antibodies released during the month of October 2016. Featured presentations of October 2016...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
November 2016
Price: USD 225.00
This pdf report contains information about TCR & CAR engineered T-cells and NK cells released during the month of October 2016. Featured...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
November 2016
Price: USD 225.00
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases This Competitive Intelligence report about Bispecific...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
June 2016
Price: USD 560.00
Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook Summary GBI Research’s latest report, "Gene Therapies: A...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
CBR Pharma Insights
September 2015
Price: USD 2,995.00
Breast cancer is one of the most fatal cancer witnessed in women and is the second leading cause of death. It refers to cancer developed in breast...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Rockville Research
April 2019
Price: USD 1,100.00
Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
WinterGreen Research
October 2017
Price: USD 4,200.00
A comparative analysis and assessment of TCR technologies, pipelines and companies from an industry perspective Therapeutic monoclonal antibodies...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
October 2013
Price: USD 1,535.00
The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
iGATE
October 2016
Price: USD 1,350.00
This report provides you with a landscape description and analysis of degrader-antibody conjugate (DAC) stakeholders, platform technologies,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
September 2024
Price: USD 2,300.00
The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
March 2014
Price: USD 1,112.00
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases This Competitive Intelligence report about Bispecific Antibodies...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
June 2019
Price: USD 900.00
The present Competitive Intelligence Report about phosphodiesterase 4 (PDE-4) Inhibitors provides a competitor evaluation in the field of mainly...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
June 2014
Price: USD 272.00
This report describes and evaluates the competitive landscape of CD22-targeted immunotherapeutics based on different treatment modalities. In B-cell...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
La Merie Publishing
November 2016
Price: USD 784.00
Ìý
